8-K Announcements
6Material company update
Mar 31, 2026·SEC
Material company update
Mar 4, 2026·SEC
Material company update
Feb 27, 2026·SEC
BrightSpring Health Services, Inc. Common Stock(BTSG)Earnings, Financials & Key Ratios
BTSG•NASDAQ
74.1× P/E·Price updated Jun 17, 2026
AboutBrightSpring Health Services, Inc. operates a home and community-based healthcare services platform in the United States. The company's platform focuses on delivering pharmacy and provider services, including clinical and supportive care in home and community settings to Medicare, Medicaid, and insured populations. It serves patients through clinical providers and pharmacists. BrightSpring Health Services, Inc. was formerly known as Phoenix Parent Holdings Inc. and changed its name to BrightSpring Health Services, Inc. in May 2021. The company was founded in 1974 and is based in Louisville, Kentucky.Show more
- Revenue$12.91B+14.6%
- EBITDA$572M+39.3%
- Net Income$191M+1155.6%
- EPS (Diluted)0.87+1029.5%
- Gross Margin11.76%-16.6%
- EBITDA Margin4.43%+21.6%
- Operating Margin3.16%+72.5%
- Net Margin1.48%+1021.3%
- ROE10.78%+775.5%
BTSG Key Insights
BrightSpring Health Services, Inc. Common Stock (BTSG) fundamental analysis — strengths, weaknesses & financial health based on data analysis
✓Strengths
- ✓Strong 5Y profit CAGR of 55.7%
- ✓Strong Piotroski F-Score: 7/9
- ✓Momentum leader: RS Rating 93 (top 7%)
- ✓High quality earnings: Operating CF exceeds net income
- ✓Strong 5Y sales CAGR of 18.3%
- ✓Trading near 52-week high
✗Weaknesses
- ✗Shares diluted 13.9% in last year
* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.
Get notified when BTSG posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
BTSG Price & Volume
BrightSpring Health Services, Inc. Common Stock (BTSG) stock price & volume — 10-year historical chart
Loading chart...
BTSG Growth Metrics
BrightSpring Health Services, Inc. Common Stock (BTSG) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Revenue CAGR
10 Years-
5 Years18.27%
3 Years18.69%
TTM21.02%
Profit CAGR
10 Years-
5 Years55.74%
3 Years-
TTM441.48%
EPS CAGR
10 Years-
5 Years48.62%
3 Years-
TTM287.79%
Return on Capital
10 Years4.78%
5 Years5.35%
3 Years5.68%
Last Year9.01%
BTSG Recent Earnings
BrightSpring Health Services, Inc. Common Stock (BTSG) EPS & revenue vs analyst estimates — last 4 quarters
●Beat EPS 6/12 qtrs (60%)●Beat Revenue 7/12 qtrs (70%)
Q2 2026Latest
May 1, 2026Metric
Actual
Est
EPS
$0.39+34.5%
$0.29
Rev
$3.6B+6.6%
$3.4B
Q1 2026
Feb 27, 2026Metric
Actual
Est
EPS
$0.33-2.9%
$0.34
Rev
$3.6B+5.0%
$3.4B
Q4 2025
Oct 31, 2025Metric
Actual
Est
EPS
$0.30+13.9%
$0.26
Rev
$3.3B+5.3%
$3.2B
Q3 2025
Aug 1, 2025Metric
Actual
Est
EPS
$0.22+15.8%
$0.19
Rev
$3.1B-0.6%
$3.2B
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q2 2026Latest | May 1, 2026 | $0.39vs $0.29+34.5% | $3.6Bvs $3.4B+6.6% |
| Q1 2026 | Feb 27, 2026 | $0.33vs $0.34-2.9% | $3.6Bvs $3.4B+5.0% |
| Q4 2025 | Oct 31, 2025 | $0.30vs $0.26+13.9% | $3.3Bvs $3.2B+5.3% |
| Q3 2025 | Aug 1, 2025 | $0.22vs $0.19+15.8% | $3.1Bvs $3.2B-0.6% |
Based on last 12 quarters of dataView full earnings history →
BTSG Peer Comparison
BrightSpring Health Services, Inc. Common Stock (BTSG) competitors in Care Delivery Networks and Value-Based Care — business model, growth, and fundamentals comparison
| Company | Market Cap | Stock Price | P/E Ratio (TTM) | Revenue Growth 1Y | Net Margin | Return on Equity (ROE) | FCF Yield | Debt / Equity |
|---|---|---|---|---|---|---|---|---|
 LFST | 3.34B | 8.61 | 430.50 | 13.85% | 1.55% | 1.56% | 0.13 | |
 ACHC | 2.16B | 23.50 | -1.93 | 5.04% | -32.84% | -40.92% | 1.24 | |
 ENSG | 9.1B | 155.84 | 26.68 | 18.72% | 6.89% | 16.61% | 1.86 | |
 ADUS | 1.75B | 93.87 | 18.02 | 23.21% | 6.89% | 9.34% | 0.19 | |
 CCRN | 425.82M | 13.17 | -4.49 | -21.56% | -9.84% | -27.1% | 0.01 | |
 OPCH | 3.4B | 21.71 | 17.09 | 13.03% | 3.64% | 15.28% | ||
 BKD | 3.24B | 13.62 | -12.27 | 4.77% | -6.58% | -234.5% | ||
 HCSG | 1.6B | 22.37 | 27.62 | 7.08% | 3.21% | 11.83% | 0.05 |
Compare BTSG vs Peers
BrightSpring Health Services, Inc. Common Stock (BTSG) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
BTSG Income Statement
BrightSpring Health Services, Inc. Common Stock (BTSG) annual income statement — 10-year revenue, gross profit & net income history
10Y historyFree accessUpdated daily
| Metric | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|
Sales/Revenue | 4.53B | 5.58B | 6.7B | 7.72B | 8.83B | 11.27B | 12.91B | 13.65B |
Revenue Growth % | - | 23.32% | 20.03% | 15.27% | 14.32% | 27.65% | 14.59% | 21.02% |
Cost of Goods Sold | 3.69B | 4.53B | 5.45B | 6.37B | 7.39B | 9.68B | 11.39B | 11.98B |
COGS % of Revenue | 81.57% | 81.21% | 81.36% | 82.46% | 83.76% | 85.9% | 88.24% | - |
Gross Profit | 833.91M▲ 0% | 1.05B▲ 25.8% | 1.25B▲ 19.0% | 1.35B▲ 8.5% | 1.43B▲ 5.9% | 1.59B▲ 10.8% | 1.52B▼ 4.4% | 1.66B▲ 0% |
Gross Margin % | 18.43% | 18.79% | 18.64% | 17.54% | 16.24% | 14.1% | 11.76% | 12.18% |
Gross Profit Growth % | - | 25.76% | 19.02% | 8.49% | 5.87% | 10.79% | -4.45% | - |
Operating Expenses | 770.59M | 883.55M | 1.01B | 1.17B | 1.29B | 1.38B | 1.11B | 1.21B |
OpEx % of Revenue | 17.03% | 15.83% | 15.14% | 15.11% | 14.58% | 12.27% | 8.6% | - |
Selling, General & Admin | 770.59M | 883.55M | 1.01B | 1.13B | 1.29B | 1.38B | 1.11B | 1.21B |
SG&A % of Revenue | 17.03% | 15.83% | 15.14% | 14.58% | 14.58% | 12.27% | 8.6% | - |
Research & Development | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
R&D % of Revenue | - | - | - | - | - | - | - | - |
Other Operating Expenses | 0 | 0 | 0 | 40.86M | 0 | 0 | 0 | 0 |
Operating Income | 63.31M▲ 0% | 165.19M▲ 160.9% | 234.18M▲ 41.8% | 187.83M▼ 19.8% | 147.18M▼ 21.6% | 206.37M▲ 40.2% | 408.06M▲ 97.7% | 449.95M▲ 0% |
Operating Margin % | 1.4% | 2.96% | 3.5% | 2.43% | 1.67% | 1.83% | 3.16% | 3.3% |
Operating Income Growth % | - | 160.91% | 41.77% | -19.79% | -21.64% | 40.22% | 97.73% | - |
EBITDA | 218.18M | 346.69M | 433.34M | 391.8M | 349.52M | 410.86M | 572.34M | 572.07M |
EBITDA Margin % | 4.82% | 6.21% | 6.47% | 5.07% | 3.96% | 3.65% | 4.43% | 4.19% |
EBITDA Growth % | - | 58.9% | 24.99% | -9.59% | -10.79% | 17.55% | 39.3% | 27.12% |
D&A (Non-Cash Add-back) | 154.87M | 181.5M | 199.16M | 203.97M | 202.34M | 204.48M | 164.28M | 122.12M |
EBIT | 63.31M | 165.19M | 234.18M | 187.83M | 147.18M | 193.65M | 408.06M | 328.5M |
Net Interest Income | -166.89M | -138.95M | -165.32M | -233.58M | -324.59M | -228.39M | -157.31M | -115.55M |
Interest Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Interest Expense | 166.89M | 138.95M | 165.32M | 233.58M | 324.59M | 228.39M | 157.31M | 154.16M |
Other Income/Expense | -166.89M | -138.95M | -165.32M | -233.58M | -324.59M | -241.11M | -270.12M | -238.15M |
Pretax Income | -103.58M▲ 0% | 26.24M▲ 125.3% | 68.86M▲ 162.5% | -45.75M▼ 166.4% | -177.41M▼ 287.8% | -34.74M▲ 80.4% | 137.94M▲ 497.1% | 211.8M▲ 0% |
Pretax Margin % | -2.29% | 0.47% | 1.03% | -0.59% | -2.01% | -0.31% | 1.07% | 1.55% |
Income Tax | -32.49M | 5.09M | 17.6M | 8.46M | -20.58M | -14.22M | 33.15M | 41.94M |
Effective Tax Rate % | 31.37% | 19.39% | 25.56% | -18.5% | 11.6% | 40.93% | 24.03% | 19.8% |
Net Income | -72.38M▲ 0% | 20.81M▲ 128.8% | 49.8M▲ 139.3% | -53.91M▼ 208.2% | -154.6M▼ 186.8% | -18.06M▲ 88.3% | 190.67M▲ 1155.6% | 309.89M▲ 0% |
Net Margin % | -1.6% | 0.37% | 0.74% | -0.7% | -1.75% | -0.16% | 1.48% | 2.27% |
Net Income Growth % | - | 128.75% | 139.3% | -208.25% | -186.8% | 88.32% | 1155.62% | 441.48% |
Net Income (Continuing) | -71.09M | 21.15M | 51.26M | -54.22M | -156.84M | -20.52M | 104.8M | 244.35M |
Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 84.32M | 3M |
Minority Interest | 53.36M | 30.39M | 25.65M | 29.31M | 27.81M | 3.73M | 11.3M | 10.51M |
EPS (Diluted) | -0.42▲ 0% | 0.12▲ 128.6% | 0.29▲ 141.7% | -0.31▼ 206.9% | -0.90▼ 190.3% | -0.09▲ 89.6% | 0.87▲ 1029.5% | 1.40▲ 0% |
EPS Growth % | - | 128.57% | 141.67% | -206.9% | -190.32% | 89.6% | 1029.49% | 287.79% |
EPS (Basic) | -0.42 | 0.12 | 0.29 | -0.31 | -0.90 | -0.09 | 0.94 | - |
Diluted Shares Outstanding | 171.19M | 171.19M | 171.19M | 171.19M | 171.19M | 193M | 219.77M | 221.32M |
Basic Shares Outstanding | 171.19M | 171.19M | 171.19M | 171.19M | 171.19M | 193M | 202.56M | 204.71M |
Dividend Payout Ratio | - | - | - | - | - | - | - | - |
BTSG Balance Sheet
BrightSpring Health Services, Inc. Common Stock (BTSG) balance sheet — assets, liabilities & shareholders' equity
| Metric | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|
Total Current Assets | 870.68M | 1.29B | 1.18B | 1.34B | 1.46B | 1.89B | 2.89B | 2.69B |
Cash & Short-Term Investments | 18.3M | 262M | 46.73M | 13.63M | 13.07M | 61.25M | 88.37M | 888.8M |
Cash Only | 18.3M | 262M | 46.73M | 13.63M | 13.07M | 61.25M | 88.37M | 888.8M |
Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Accounts Receivable | 622.28M | 700.84M | 805M | 868.35M | 1.01B | 1.15B | 989.72M | 1.11B |
Days Sales Outstanding | 50.19 | 45.84 | 43.87 | 41.05 | 41.8 | 37.23 | 27.98 | 28.58 |
Inventory | 198.47M | 300.06M | 299.22M | 430.52M | 402.78M | 640.57M | 815.18M | 560.17M |
Days Inventory Outstanding | 19.63 | 24.17 | 20.04 | 24.68 | 19.89 | 24.16 | 26.12 | 20.1 |
Other Current Assets | 23.37M | 16.41M | 12.66M | 13.51M | 13.19M | 24.59M | 1B | 126.81M |
Total Non-Current Assets | 2.95B | 3.25B | 4.33B | 4.1B | 4.08B | 4.03B | 3.52B | 3.52B |
Property, Plant & Equipment | 432.55M | 450.71M | 524.64M | 475.27M | 513.35M | 500.03M | 376.32M | 375.22M |
Fixed Asset Turnover | 10.46x | 12.38x | 12.77x | 16.24x | 17.19x | 22.53x | 34.31x | 38.22x |
Goodwill | 1.41B | 1.67B | 2.66B | 2.58B | 2.61B | 2.67B | 2.55B | 2.53B |
Intangible Assets | 1.07B | 1.1B | 1.11B | 975.86M | 881.48M | 811.48M | 557.55M | 536.88M |
Long-Term Investments | 2.37M | 2.48M | 2.66M | 736K | 720K | 670K | 0 | 14.54M |
Other Non-Current Assets | 34.56M | 32.22M | 35.78M | 68.93M | 72.12M | 43.8M | 39.71M | 78.35M |
Total Assets | 3.82B▲ 0% | 4.54B▲ 19.0% | 5.51B▲ 21.4% | 5.44B▼ 1.3% | 5.53B▲ 1.7% | 5.93B▲ 7.1% | 6.41B▲ 8.2% | 6.21B▲ 0% |
Asset Turnover | 1.19x | 1.23x | 1.21x | 1.42x | 1.60x | 1.90x | 2.01x | 2.22x |
Asset Growth % | - | 18.96% | 21.41% | -1.31% | 1.68% | 7.11% | 8.22% | 25.08% |
Total Current Liabilities | 621.97M | 742.79M | 892.16M | 932.51M | 1.25B | 1.43B | 1.85B | 1.55B |
Accounts Payable | 252.75M | 355.75M | 408.11M | 526.92M | 641.61M | 941.29M | 1.22B | 1.09B |
Days Payables Outstanding | 24.99 | 28.65 | 27.33 | 30.21 | 31.68 | 35.5 | 39.02 | 32.2 |
Short-Term Debt | 18.48M | 22.5M | 40.54M | 30.41M | 32.27M | 48.73M | 102.07M | 105.09M |
Deferred Revenue (Current) | 3.31M | 22.76M | 10.49M | 29.04M | 30.85M | 11M | 0 | 16.53M |
Other Current Liabilities | 14.19M | 16.18M | 95.87M | 80.73M | 118.14M | 98.84M | 529.02M | 351.89M |
Current Ratio | 1.40x | 1.74x | 1.32x | 1.44x | 1.17x | 1.33x | 1.57x | 1.74x |
Quick Ratio | 1.08x | 1.33x | 0.99x | 0.98x | 0.84x | 0.88x | 1.12x | 1.38x |
Cash Conversion Cycle | 44.83 | 41.35 | 36.57 | 35.53 | 30.01 | 25.89 | 15.08 | 16.48 |
Total Non-Current Liabilities | 2.49B | 3.06B | 3.82B | 3.72B | 3.67B | 2.85B | 2.68B | 2.68B |
Long-Term Debt | 2.16B | 2.67B | 3.39B | 3.36B | 3.33B | 2.56B | 2.59B | 149.75M |
Capital Lease Obligations | 190.15M | 211.95M | 252.09M | 204.91M | 224.18M | 212.6M | 149.96M | 429.92M |
Deferred Tax Liabilities | 65.68M | 121.64M | 98.16M | 79.39M | 23.67M | 0 | 6.18M | 17.79M |
Other Non-Current Liabilities | 65.46M | 57.98M | 77.04M | 75.94M | 91.94M | 71.76M | -68.86M | 2.52B |
Total Liabilities | 3.11B | 3.81B | 4.71B | 4.66B | 4.92B | 4.27B | 4.53B | 4.22B |
Total Debt | 2.44B | 2.97B | 3.77B | 3.68B | 3.67B | 2.9B | 2.84B | 254.83M |
Net Debt | 2.43B | 2.71B | 3.72B | 3.66B | 3.66B | 2.84B | 2.75B | -633.96M |
Debt / Equity | 3.44x | 4.04x | 4.71x | 4.69x | 5.99x | 1.76x | 1.51x | 0.13x |
Debt / EBITDA | 11.20x | 8.58x | 8.70x | 9.39x | 10.50x | 7.07x | 4.97x | 0.45x |
Net Debt / EBITDA | 11.12x | 7.82x | 8.59x | 9.35x | 10.46x | 6.92x | 4.81x | -1.11x |
Interest Coverage | 0.38x | 1.19x | 1.42x | 0.80x | 0.45x | 0.85x | 2.59x | 2.13x |
Total Equity | 710.23M▲ 0% | 735.38M▲ 3.5% | 800.46M▲ 8.9% | 784.08M▼ 2.0% | 612.55M▼ 21.9% | 1.65B▲ 169.6% | 1.89B▲ 14.2% | 1.98B▲ 0% |
Equity Growth % | - | 3.54% | 8.85% | -2.05% | -21.88% | 169.63% | 14.22% | 52.46% |
Book Value per Share | 4.15 | 4.30 | 4.68 | 4.58 | 3.58 | 8.56 | 8.58 | 8.94 |
Total Shareholders' Equity | 656.87M | 704.98M | 774.82M | 754.78M | 584.74M | 1.65B | 1.88B | 1.98B |
Common Stock | 745.88M | 745.17M | 1.18M | 1.18M | 1.18M | 1.74M | 1.92M | 1.93M |
Retained Earnings | -94.28M | -51.75M | 971K | -45.72M | -200.32M | -222.16M | -74.65M | 14.13M |
Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Accumulated OCI | 132K | 185K | 217K | 21.19M | 12.54M | 1.42M | -6.69M | -1.26M |
Minority Interest | 53.36M | 30.39M | 25.65M | 29.31M | 27.81M | 3.73M | 11.3M | 10.51M |
BTSG Cash Flow Statement
BrightSpring Health Services, Inc. Common Stock (BTSG) cash flow — operating, investing & free cash flow history
| Metric | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|
Cash from Operations | 110.91M | 222.64M | 270.17M | -4.65M | 210.78M | 23.77M | 490.17M | 511.51M |
Operating CF Margin % | 2.45% | 3.99% | 4.03% | -0.06% | 2.39% | 0.21% | 3.8% | - |
Operating CF Growth % | - | 100.74% | 21.35% | -101.72% | 4630.05% | -88.72% | 1961.79% | 895.05% |
Net Income | -71.09M | 21.15M | 51.26M | -54.22M | -156.84M | -20.52M | 190.67M | 309.89M |
Depreciation & Amortization | 154.87M | 181.5M | 199.16M | 203.97M | 202.34M | 204.48M | 164.28M | 161.21M |
Stock-Based Compensation | 3.71M | 6.27M | 4.52M | 3.55M | 3.92M | 69.17M | 70.1M | 58.09M |
Deferred Taxes | -34.41M | 22.6M | 6.49M | -27.96M | -52.63M | -25.91M | 0 | -4.03M |
Other Non-Cash Items | 64.31M | 27.2M | 38.85M | 94.48M | 54.56M | 66.63M | 83.67M | -600K |
Working Capital Changes | -6.48M | -36.08M | -30.11M | -224.47M | 159.44M | -270.07M | -18.54M | -13.43M |
Change in Receivables | -53.95M | -58.91M | -93M | -150.47M | -127.25M | -179.04M | -131.29M | -165.96M |
Change in Inventory | -16.03M | -95.73M | 4.29M | -131.83M | 28.66M | -236.51M | -177.91M | -26.37M |
Change in Payables | 46.78M | 100.43M | 63.54M | 133.47M | 105.65M | 303.21M | 264.17M | 231.06M |
Cash from Investing | -1.53B | -452.87M | -1.19B | 45.36M | -134.43M | -140.24M | -310.18M | 466.5M |
Capital Expenditures | -51.22M | -51.91M | -59.27M | -70.11M | -73.53M | -80.91M | 0 | -3.91M |
CapEx % of Revenue | 1.13% | 0.93% | 0.88% | 0.91% | 0.83% | 0.72% | 0.74% | 0.03% |
Acquisitions | -1.48B | -402.01M | -1.13B | 113.33M | -63.06M | -59.8M | 0 | -35.45M |
Investments | - | - | - | - | - | - | - | - |
Other Investing | 1.41M | 1.05M | 1.7M | 2.13M | 2.15M | 473K | -310.18M | 505.87M |
Cash from Financing | 1.41B | 473.94M | 705.22M | -73.81M | -76.91M | 164.65M | -152.77M | -141.86M |
Debt Issued (Net) | 1.27B | 493.17M | 726.86M | -68.93M | -66.14M | -829.36M | -127.12M | 78.5M |
Equity Issued (Net) | 261.14M | -1.12M | 12.39M | 0 | -650K | 1.04B | -17.89M | -32.57M |
Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Share Repurchases | -12.29M | -1.12M | -417K | 0 | -650K | -650K | -43.17M | -103.17M |
Other Financing | -118.59M | -18.11M | -34.03M | -4.88M | -10.12M | -50.83M | -7.75M | -187.79M |
Net Change in Cash | -12.23M▲ 0% | 243.71M▲ 2092.9% | -215.27M▼ 188.3% | -33.11M▲ 84.6% | -557K▲ 98.3% | 48.18M▲ 8750.3% | 27.12M▼ 43.7% | 837M▲ 0% |
Free Cash Flow | 59.69M▲ 0% | 170.73M▲ 186.0% | 210.9M▲ 23.5% | -74.77M▼ 135.5% | 137.26M▲ 283.6% | -57.14M▼ 141.6% | 394.69M▲ 790.7% | 507.6M▲ 0% |
FCF Margin % | 1.32% | 3.06% | 3.15% | -0.97% | 1.56% | -0.51% | 3.06% | 3.72% |
FCF Growth % | - | 186.03% | 23.52% | -135.45% | 283.58% | -141.63% | 790.75% | 298.11% |
FCF per Share | 0.35 | 1.00 | 1.23 | -0.44 | 0.80 | -0.30 | 1.80 | 2.29 |
FCF Conversion (FCF/Net Income) | -1.53x | 10.70x | 5.43x | 0.09x | -1.36x | -1.32x | 2.57x | 1.64x |
Interest Paid | 134.38M | 129.57M | 126.95M | 213.31M | 303.53M | 211.39M | 183.51M | -53.8M |
Taxes Paid | 3.72M | 3M | 0 | 28.85M | 37.5M | 24.95M | 26.97M | -245K |
BTSG Key Ratios
BrightSpring Health Services, Inc. Common Stock (BTSG) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios
| Metric | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|---|---|
Return on Equity (ROE) | 2.88% | 6.48% | -6.8% | -22.14% | -1.6% | 10.78% | 16.68% |
Return on Invested Capital (ROIC) | 3.76% | 4.41% | 3.14% | 2.53% | 3.53% | 6.7% | 9.15% |
Gross Margin | 18.79% | 18.64% | 17.54% | 16.24% | 14.1% | 11.76% | 12.18% |
Net Margin | 0.37% | 0.74% | -0.7% | -1.75% | -0.16% | 1.48% | 2.27% |
Debt / Equity | 4.04x | 4.71x | 4.69x | 5.99x | 1.76x | 1.51x | 0.13x |
Interest Coverage | 1.19x | 1.42x | 0.80x | 0.45x | 0.85x | 2.59x | 2.13x |
FCF Conversion | 10.70x | 5.43x | 0.09x | -1.36x | -1.32x | 2.57x | 1.64x |
Revenue Growth | 23.32% | 20.03% | 15.27% | 14.32% | 27.65% | 14.59% | 21.02% |
Related:BTSG Dividend History·BTSG Revenue History·BTSG Price History·BTSG P/E History·BTSG Financial Ratios·BTSG Institutional Holders
BTSG SEC Filings & Documents
BrightSpring Health Services, Inc. Common Stock (BTSG) SEC filings — annual & quarterly reports (10-K, 10-Q)
BTSG Frequently Asked Questions
BrightSpring Health Services, Inc. Common Stock (BTSG) stock FAQ — growth, dividends, profitability & financials explained
Growth & Financials
BrightSpring Health Services, Inc. Common Stock (BTSG) reported $13.65B in revenue for fiscal year 2025. This represents a 202% increase from $4.53B in 2019.
BrightSpring Health Services, Inc. Common Stock (BTSG) grew revenue by 14.6% over the past year. This is steady growth.
Yes, BrightSpring Health Services, Inc. Common Stock (BTSG) is profitable, generating $309.9M in net income for fiscal year 2025 (1.5% net margin).
Dividend & Returns
BrightSpring Health Services, Inc. Common Stock (BTSG) has a return on equity (ROE) of 10.8%. This is reasonable for most industries.
BrightSpring Health Services, Inc. Common Stock (BTSG) generated $507.6M in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.